(3S)-14,16-Dihy-droxy-3-methyl-3,4,5,6,9,10,11,12-octa-hydro-1H-2-benzoxacyclo-tetra-decine-1,7(8H)-dione (zearalanone) monohydrateCarbonate-coordinated metal complexes precede the formation of liquid amorphous mineral emulsions of divalent metal carbonates.Amelogenin nanoparticles in suspension: deviations from spherical shape and pH-dependent aggregationThermally highly stable amorphous zinc phosphate intermediates during the formation of zinc phosphate hydrate.The challenging case of the theophylline-benzamide cocrystal.In Situ Investigation of a Self-Accelerated Cocrystal Formation by Grinding Pyrazinamide with Oxalic Acid.Koenigs-Knorr reaction of fusel alcohols with methyl (1-bromo-2,3,4-tri-O-acetyl-α-D-glucopyranosid)uronate leading to the protected alkyl glucuronides-crystal structures and high resolution 1H and 13C NMR data.Bismuth hexagons: facile mass synthesis, stability and applications.Strong stabilization of amorphous calcium carbonate emulsion by ovalbumin: gaining insight into the mechanism of 'polymer-induced liquid precursor' processesrac-2,3-Dibromo-propionamide.In Situ Monitoring of the Mechanosynthesis of the Archetypal Metal-Organic Framework HKUST-1: Effect of Liquid Additives on the Milling Reactivity.Ca- and Sr-tetrafluoroisophthalates: mechanochemical synthesis, characterization, and ab initio structure determination.Reversible Gas-Solid Ammonia N-H Bond Activation Mediated by an Organopalladium Complex.Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.Warming up for mechanosynthesis - temperature development in ball mills during synthesis.The crystallisation of copper(ii) phenylphosphonates.The structure and in situ synthesis investigation of isomorphic mononuclear molecular metal phenylphosphonates.1-(4-Bromo-3,5,5,6,8,8-hexa-methyl-5,6,7,8-tetra-hydro-naphthalen-2-yl)ethan-1-one: a precursor for phase-I metabolite of AHTN.Lysergol monohydrate.Ergometrinine.rac-(1R,2R,4S)-1,2-Dibromo-4-[(1R)-1,2-dibromo-eth-yl]cyclo-hexa-ne.Direct in situ investigation of milling reactions using combined X-ray diffraction and Raman spectroscopy.Alternariol.Methyl 3,5,5,6,8,8-hexa-methyl-5,6,7,8-tetra-hydro-naphthalene-2-carboxyl-ate (AHTN-COOMe).N-(β-Carb-oxy-eth-yl)-α-isoleucine.(3S,7R)-7,14,16-Trihy-droxy-3-methyl-3,4,5,6,7,8,9,10,11,12-deca-hydro-1H-2-benzoxacyclo-tetra-decin-1-onen-Propyl 2,3,4,6-tetra-O-acetyl-β-d-glucopyran-oside.Ergotamininerac-1-(2-Amino-carbonyl-2-bromo-eth-yl)pyridinium bromide.Deacetyl- tenuazonic acid.3-{1-[(2,4-Dinitrophenyl)hydrazino]-ethyl-idene}-5-(1-methylpropyl)pyrrolidine-2,4-dioneDeacetyl tenuazonic acid p-toluene-sulfonyl-hydrazonel-Nebiviololinium chloride dihydrate.(3S,11Z)-14,16-Dihy-droxy-3-methyl-3,4,5,6,9,10-hexa-hydro-1H-2-benz-oxacyclo-tetra-decine-1,7(8H)-dione (cis-zearalenone): a redetermination.Triacetone triperoxide (TATP): hapten design and development of antibodies.Combined synchrotron XRD/Raman measurements: in situ identification of polymorphic transitions during crystallization processes.Mechanism of gold nanoparticle formation in the classical citrate synthesis method derived from coupled in situ XANES and SAXS evaluation.Real-time monitoring of copolymer stabilized growing gold nanoparticles.Isopropyl 2,3,4,6-tetra-O-acetyl-β-d-glucopyran-oside.Nucleation and growth of gold nanoparticles studied via in situ small angle X-ray scattering at millisecond time resolution.
P50
Q24628842-D89F48F1-760A-4B82-A539-7578BDFB1B32Q30475176-2668524C-66D9-48DE-91AA-12A65FE93FA7Q30483438-3F16D81B-79E2-4DB8-8F85-3F9405BB3959Q30885126-B1BA0697-24F0-4C27-870C-F6547C7F4752Q31052880-677C5A55-5139-4662-888E-60CC10EAB30EQ31115439-8EF43DDA-0359-4F44-806F-037B7843B0A5Q34188815-367606FB-E73C-4876-B184-2535B0A052CBQ34234689-6FD225CC-D66D-4EAC-AF1F-A590AE5FBB70Q35207873-5B3C5417-3939-447E-ACA2-E899557B8214Q36600925-E47BF99B-61FE-4DFC-AF9B-35B15555CF57Q38767704-78AA2621-0FB5-4C0F-8190-BE203B2C50FEQ38828959-C1775E20-9F46-4E63-9C0C-9BD25F4DD288Q38834655-780491C9-84E9-4E15-8008-770C7F0B337DQ39006093-D3C667E7-1CFD-4017-83E2-2E5A41AB8EA5Q39014615-310613A2-1EA7-4D59-A42E-8FFE808BDE3FQ39296556-4DA37C2A-5EC2-4D7F-812A-5DFA9562C7E0Q39759533-E0DA6DB3-1E5B-41AE-802D-131599EC7670Q39927307-E4B38352-A2B2-4095-AE5B-CC7BF5AD1DD0Q40945229-E1A8D6F8-7CF9-460B-AD30-317CAC48B527Q41394770-B72F4D3F-8E88-44A0-9E81-E0B7B84106FEQ41515164-A45E786D-5F89-4D9A-8507-2FD9EB955558Q41662453-02559382-63FC-4E01-81C9-068B618AEAFDQ41833529-B430B350-43C3-4266-A33A-47660CDC07C8Q41997138-24C163D7-D290-4E20-A19F-299A4CA6154EQ41999654-6E144078-142A-4D33-97A1-CA11C233B7ACQ42049552-588AA55E-DAD1-47B1-BAC2-AF82260162CBQ42156601-7D0C0CF1-F10F-4AD8-A7F7-D01BFA63A510Q42165794-56030DBC-F513-48F1-8E00-2D822A7AEFF1Q42208076-DD2C04BF-F038-4629-B920-260EE4ABB447Q42265009-D5BBED5C-55CD-42DB-A37D-7826B48E6798Q42372202-FFED0FE0-8750-4FA5-B6C0-9D603A3EB621Q42382995-B6913BA6-A52E-4D19-80A4-A0C25E37DBEEQ42588304-97A4E7C7-E57E-4D27-A9DA-F0EB8CC408BBQ42591351-77039402-F581-4622-BCE1-28AB595E7E01Q42918303-4AB74CE4-FCC6-4E69-AC0C-61BE8DE2F807Q43133598-81AB49FB-494C-4B2D-871C-2914CF07566EQ43183985-739D4FA3-9AC8-49DE-BFF6-232EA352E6FFQ43190119-E87D9458-6CF0-4001-97AA-33CD1E3516BBQ43236525-A56EC4C3-5A2B-4F46-AE20-2B924D093FD3Q44615429-6E9FBC5C-818D-4DE0-AD0F-371358A07EE8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Franziska Emmerling
@ast
Franziska Emmerling
@en
Franziska Emmerling
@es
Franziska Emmerling
@nl
Franziska Emmerling
@sl
type
label
Franziska Emmerling
@ast
Franziska Emmerling
@en
Franziska Emmerling
@es
Franziska Emmerling
@nl
Franziska Emmerling
@sl
prefLabel
Franziska Emmerling
@ast
Franziska Emmerling
@en
Franziska Emmerling
@es
Franziska Emmerling
@nl
Franziska Emmerling
@sl
P106
P21
P31
P373
Franziska Emmerling
P496
0000-0001-8528-0301